Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.1560
+0.0140 (9.86%)
Jan 23, 2026, 3:00 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 10.59 million as of January 23, 2026. Its market cap has decreased by -63.87% in one year.
Market Cap
10.59M
Enterprise Value
9.21M
Revenue
10.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 10.59M, a decrease of -89.06%. That is a compound annual growth rate of -32.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 10.59M | -5.33% |
| Dec 30, 2025 | 11.19M | -54.37% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.66T |
| Genmab | 128.62B |
| Coloplast | 123.37B |
| Demant | 48.78B |
| BioPorto | 495.10M |
| Pharma Equity Group | 128.89M |
| ViroGates | 103.03M |
| Scandinavian Medical Solutions | 97.32M |